• Infectious Disease
    Founder and Chairman of the "International Nosocomial Infection Control Consortium (INICC)", Buenos Aires, Argentina
    Founder and Chairman of the "International Nosocomial Infection Control Consortium (INICC)", Buenos Aires, Argentina
    • Founder and Chairman at International Nosocomial Infection Control Consortium (INICC)

    Dr. Rosenthal is a specialist in Internal Medicine and Infectious Diseases in Buenos Aires. He holds an Infectious Diseases fellowship at the University of Wisconsin. He is a graduate in Clinical Effectiveness, from Harvard University. He is certified on Infection Control and Hospital Epidemiology.

    Dr. Rosenthal is the founder and chairman of the International Nosocomial Infection Control Consortium (INICC), a nonprofit international research center which focuses on Healthcare-Associated Infections, leading 3,000 researchers in 500 cities in 66 countries, of the 6 WHO regions, among many others, conducting a cohort prospective multinational study with more than 300,000 patients hospitalized at Intensive Care Units worldwide.

    He has collaborated with Center for Diseases Control and Prevention (CDC) and currently with Microbiology Lab of US Army (NAMRU) on international infection control programs. He is Coauthor of Joint Commission International Guidelines to prevent Central line associated blood stream infections. He is a Task Force Member and Reviewer of the Infection Control Guidelines for the World Health Organization (WHO). He has collaborated with edition of the Infection Control Guidelines of Argentina, Brazil, Colombia, Peru, Hong Kong, Taiwan, China and several other countries.

    He is an editorial board member and scientific reviewer of several international peer reviewed journals, such as “Lancet”, “American Journal of Infection Control (AJIC)”; “Infection Control and Hospital Epidemiology” (ICHE); and several others.

    Being an author of more than 400 scientific publications and book chapters worldwide, Dr. Rosenthal has received several awards granted at different international scientific meetings, including SHEA, APIC, IFIC, Pan American Meetings, and others. Dr. Rosenthal was a speaker in more than 5,000 conferences and symposiums in more than 100 countries, at the five continents, during last 28 years

  • I obtained my Bachelor of Science degree from Nebraska Wesleyan University in Lincoln, Nebraska. I received my doctor of medicine, Master of Science, and Master of Public Health degrees from New York Medical College in Valhalla, NY. I completed my Internal Medicine residency program at the University of Texas Health Science Center at San Antonio, TX.

    I have been working as a hospitalist since 2002, and the hospitals that I worked at between 2002 and 2008 included Catskills Regional Medical Center (Harris, NY), Tucson Medical Center (Tucson, AZ) and Christus St. Michael Hospital (Texarkana, TX).

    I have been a faculty member in the Department of Medicine at Emory University in Atlanta since 2008, and I became an Assistant Professor in 2011. I have a great interest in reducing the prevalence of healthcare associated infections, and in particular, catheter-associated urinary tract infections.

    • Family Medicine

    M. Moe Bell, MD MPH, Director MD/MPH program and Clinical Professor of Family, Community, and Preventive Medicine at the University of Arizona College of Medicine- Phoenix

    • Director of the Lifestyle Research Center & Associate Professor of Nursing at Avondale College

    Associate Professor Brett Mitchell is an Associate Professor of Nursing and Director of the Lifestyle Research Centre at Avondale College, New South Wales, Australia. He also holds an honorary fellow position at Australian Catholic University. Brett has authored over 100 papers and oral presentations that relate to healthcare associated infections and infection control. Brett is a member of several national Australian committees, including antimicrobial utilisation and resistance, the Australian College for Infection Prevention and Control and Chairs a National Health and Medic al Research Council Committee responsible for developing new national evidence based guidelines for the prevention of infections in Australian healthcare facilities. A/Prof Mitchell is the Editor-in-Chief of an international peer reviewed journal, Infection, Disease and Health ( This journal has a strong focus on infection prevention and control and can be followed on Twitter (@IDHjournal). Brett has lead infection control teams and programs at a hospital, multi-centred and State level. He has a particular interest in urinary tract infections and has very recently completed a multicentre point prevalence study across hospitals and aged care facilities in Australia. He also led a study that identified an increased length of stay associated with healthcare associated urinary tract infections. An Australian based infection prevention and control blog has recently being established, with Brett being one of the contributors. You can follow Brett on Twitter @bgm_2012.

    • Infectious Disease
    • Professor of Medicine, Senior Consultant Infectious Diseases Physician at National University of Singapore

    Dr Paul Anantharajah Tambyah is currently Professor of Medicine at the National University of Singapore and Senior Consultant Infectious Diseases Physician at the National University Hospital. After graduating from the National University of Singapore’s medical school and military service in the Singapore Armed Forces, he went on to complete training in Infectious Diseases at the University of Wisconsin under Dr Dennis Maki. Since returning to Singapore in 1999, he has been involved in a number of national and international committees including serving as founding head of the division of infectious diseases, National University of Singapore, assistant dean of the medical school till 2007 and immediate past president of the Society of Infectious Diseases (Singapore). He was a board member of the Society of Healthcare Epidemiology in America and the Annual Meeting Planning Committee of the Infectious Diseases Society of America. He is currently Secretary General of the Asia Pacific Society of Clinical Microbiology and Infection and an executive committee member of the International Society of Infectious Diseases. His main research interests are in device associated infections and in emerging infectious diseases including antimicrobial resistance. He has published extensively on catheter associated urinary tract infections (CAUTI) and is principal investigator on three grants related to development of novel catheters as well as therapeutics for CAUTI. He is a co-author on the Infectious Diseases Society of America guideline on CAUTI, the European and Asian CAUTI guideline and the forthcoming CAUTI guideline from the Asian Association of UTI and STDs.

    • minority health disparities
    • rural health
    • Professor in the Department of Health Services Policy and Management at Arnold School of Public Health at the University of South Carolina

    Dr. Janice C. Probst is a tenured professor in the Department of Health Services Policy and Management at the Arnold School of Public Health, University of South Carolina and Principal Investigator for the South Carolina Rural Health Research Center (SCRHRC). The SCRHRC derives its core funding from a center grant from the Federal Office of Rural Health Policy; this grant has been continuously refunded since 2000. The focus of the SCRHRC is health and health service disparities experienced by rural residents, particularly rural minority populations. Additional SCRHRC statistical research and intervention projects are supported by other Federal agencies and foundation grants. Dr. Probst has authored or co-authored more than 110 peer-reviewed publications and more than 180 competitive conference abstracts. She has previously served on the editorial boards for the Journal of Rural Health and Family Medicine. She currently serves on the Health Equity Council within the National Rural Health Association (NRHA), and is a member of the Healthcare Systems and Value Research Study Section within AHRQ. In May, 2016 NRHA gave Dr. Probst its “volunteer of the year” award for her contribution to NRHA committees and programs. Her other accolades include a Regent’s Award from the American College of Healthcare Executives (2005), the NRHA Distinguished Researcher award (2008), and a Doctor of Humane Letters (honoris causa) from A.T. Still University (2013).

    • Internal Medicine
    • Pediatrics
    • Assistant Professor of Internal Medicine and Pediatrics at VA Ann Arbor and University of Michigan

    Dr. Meddings is a board certified Assistant Professor of Internal Medicine and Pediatrics at the University of Michigan Health System, and she cares for hospitalized patients at the Ann Arbor VA Medical Center. Much of her recent research has focused on evaluation and development of evidence-based interventions for prevention of catheter-associated urinary tract infection. She has performed several systematic reviews involving interventions to reduce unnecessary catheter use, including meta-analyses demonstrating that the use of urinary catheter reminders and stop orders can reduce CAUTIs by > 50%,1-3 and interventions implemented in 2 AHRQ-funded collaboratives to reduce CAUTI in the acute-care and long-term care settings.4-7 She also developed and led a project using the RAND/UCLA Appropriateness Method to formally rate the appropriateness of 3 types of urinary catheters (indwelling urinary catheters, intermittent straight catheter, and external catheters) for hundreds of clinical scenarios commonly encountered in hospitalized adults on medical services; this work was recently published in Annals of Internal Medicine.8 Her work also has focused on evaluation of measures of urinary catheter use for surveillance and public reporting, and the challenges in implementing value-based purchasing programs using metrics involving urinary catheter use and pressure ulcer development.9-13 Dr. Meddings is a member of the Infectious Disease Society of America, The Society of Hospital Medicine, AcademyHealth, The Society of General Internal Medicine and the Infectious Diseases Society of America.

    • Infectious Disease
    • Professor of Clinical Medicine, Chief of Medicine of the Miami VA Healthcare System, Clinical Director of the Infectious Diseases Division, Medical Director of Infection Control and Employee Health at University of Miami Miller School of Medicine

    Thomas M. Hooton, MD is a Professor of Clinical Medicine at the University of Miami Miller School of Medicine, Miami, FL where he is currently the Chief of Medicine of the Miami VA Healthcare System, Clinical Director of the Infectious Diseases Division and Medical Director of Infection Control and Employee Health of the University of Miami Health System. He received his MD from the University of Texas Southwestern Medical School in Dallas, Texas, and then moved to Seattle, WA, for his internship and residency in Medicine at the University of Washington. He spent 5 years at the Centers for Disease Control in Atlanta, GA, as an Epidemic Intelligence Officer (EIS) and researcher in hospital associated infections. He returned to the University of Washington to do an Infectious Disease Fellowship and Chief Residency in Medicine. He joined and remained on the faculty at the University of Washington for 22 years until he moved to the University of Miami in 2006. His principal research focus has been to better understand the epidemiology, pathogenesis, and treatment of urinary tract infection in healthy young women. He has authored or co-authored over 140 peer-reviewed journal articles and over 200 other articles, book chapters and abstracts in the fields of UTI, STDs, HIV/AIDS and antimicrobial stewardship. He has chaired and/or served on Infectious Disease Society of America (IDSA) guideline committees that have published guidelines on screening and treatment of asymptomatic bacteriuria, catheter-associated UTI, uncomplicated UTI and antimicrobial stewardship.

Powered by Medstro